Premium
Neuraxis Inc (NRXS)
AMEX
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ... NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. Show more
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will...
CARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
CARMEL, Ind., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Nov. 04, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Oct. 29, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -2.02429149798 | 2.47 | 2.88 | 2.35 | 24911 | 2.3933344 | CS |
| 4 | -0.27 | -10.0371747212 | 2.69 | 3.34 | 2.25 | 37118 | 2.5024039 | CS |
| 12 | -0.48 | -16.5517241379 | 2.9 | 3.78 | 2.05 | 25796 | 2.71311785 | CS |
| 26 | -0.45 | -15.6794425087 | 2.87 | 3.78 | 2.05 | 14976 | 2.77327012 | CS |
| 52 | -0.12 | -4.72440944882 | 2.54 | 3.89 | 2.0001 | 12823 | 2.873792 | CS |
| 156 | -3.88 | -61.5873015873 | 6.3 | 6.93 | 1.8 | 20081 | 3.40176331 | CS |
| 260 | -3.88 | -61.5873015873 | 6.3 | 6.93 | 1.8 | 20081 | 3.40176331 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| OPTTOcean Power Technologies Inc | US$ 1,21 (9,01%) | 2,06M |
| CTMCastellum Inc | US$ 1,93 (15,57%) | 1,82M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 31,49 (5,60%) | 1,57M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 10,60 (3,92%) | 1,15M |
| SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 19,31 (-5,39%) | 882,37k |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
